Levobunolol

Levobunolol
Clinical data

Trade names	Betagan
AHFS/Drugs.com	Monograph
MedlinePlus	a686011
Pregnancy category	C
Routes of administration	Topical (eye drops)
ATC code	S01ED03 (WHO)
Legal status
Legal status	US: ℞-only
Pharmacokinetic data
Biological half-life	20 hours
Identifiers
IUPAC name (S)-5-{[3-(tert-Butylamino)-2-hydroxypropyl]oxy}-3,4-dihydronaphthalen-1(2H)-one
CAS Number	47141-42-4^Y
PubChem CID	39468
IUPHAR/BPS	570
DrugBank	DB01210^Y
ChemSpider	36089^Y
UNII	G6317AOI7K
KEGG	D08115^Y
ChEBI	CHEBI:6438^Y
ChEMBL	CHEMBL1201237^N
Chemical and physical data
Formula	C₁₇H₂₅NO₃
Molar mass	291.385 g/mol
3D model (Jmol)	Interactive image
SMILES O=C2c1cccc(OC[C@@H](O)CNC(C)(C)C)c1CCC2
InChI InChI=1S/C17H25NO3/c1-17(2,3)18-10-12(19)11-21-16-9-5-6-13-14(16)7-4-8-15(13)20/h5-6,9,12,18-19H,4,7-8,10-11H2,1-3H3/t12-/m0/s1^Y Key:IXHBTMCLRNMKHZ-LBPRGKRZSA-N^Y
^NY (what is this?)

Levobunolol (AK-Beta, Liquifilm, Betegan) is a non-selective beta blocker. It is used topically to manage glaucoma.